Interplay of lipidomics and gut microbiota metabolites with lipid-rich coronary plaques
Atherosclerosis of the coronary arteries is a complex, degenerative disease, leading to obstructive coronary artery disease and myocardial infarction. Lipid-rich plaques have a high clinical relevance, since this plaque entity frequently contains a high proportion of inflammatory cells and only separates from the vessel lumen by a thin fibrous cap. The present project evaluates predictors and determinants of lipid-rich coronary plaque burden.
Joint ForTra-BIH Workshop on Gene and Cell Therapy (GCT): Where do we stand and where do we want to go?
What: Joint ForTra-BIH Workshop on Gene and Cell Therapy (GCT): Where do we stand and where do we want to go?
Date: Monday, May 18 and Tuesday, May 19, 2026
Target audience: Curious and passionate professionals in the field of Gene and Cell Therapy — especially translational scientists eager to move their research into real-world clinical impact.
Where: Frankfurt am Main
Preparation of clinical trials with microbeam radiation therapy at a novel compact x-ray source
Radiotherapy is a cornerstone of cancer treatment, yet its clinical effectiveness remains limited by damage to healthy tissue. Microbeam Radiation Therapy (MRT) represents a promising approach to overcome this fundamental limitation.
MRT delivers radiation in extremely narrow microbeams on a micrometer scale. Preclinical studies have demonstrated strong tumor control combined with exceptional normal tissue tolerance, resulting in a substantially enlarged therapeutic window.
5. Interdisciplinary Network Symposium: Else Kröner Symposium
Look forward to three days full of inspiration, networking, and practical insights with exciting keynotes, interactive sessions, and presentations on the latest research techniques. A diverse program awaits you, designed to help you find the right balance between clinical work and research.
The symposium is organized by the scholarship recipients of the Clinician Scientist Program "RINAI“ ("Regulation of Inflammation in Neurological, Autoimmune and Infectious Diseases") of the Ruhr University Bochum.
Ru(II) Polypyridyl Complexes as Sonosensitizers for Sonodynamic Therapy
Cancer remains one of the leading causes of death worldwide, underscoring the strong need for effective yet minimally invasive therapeutic approaches. Conventional treatments such as surgery, chemotherapy, and radiotherapy are often effective but frequently cause significant side effects due to damage to healthy tissue.
Optimizing the transition of preterm and term infants after birth
After birth, the newborn is no longer supplied with oxygen via the umbilical cord and must start breathing. A smooth transition during this period is very important for survival without long-term disability, especially in very preterm infants. It is therefore essential to optimize this transitional period in order to give these children the best possible start into life.
Step: Physical mobility in healthy and pathological aging
Further information: At the core of the Else Kröner Doctoral Program “Schritt” is the study of upright gait as well as diseases and aging processes that can lead to gait disturbances and, consequently, to impairments in mobility. Within their research projects, the doctoral researchers investigate various aspects of gait disorders across different disease entities, including multiple sclerosis, osteoporosis, osteoarthritis, Alzheimer’s disease, and Parkinson’s disease.
Production of GMP-peptide vaccines for the phase I PRO-ACTIVE trial in melanoma evaluating a novel cellular therapy approach
To improve treatment success and thus the quality of life and life expectancy of cancer patients, new therapies targeting the individual tumor are needed. Innovative immunotherapeutic strategies, such as personalized vaccines or cell-based therapies represent promising approaches for the targeted treatment of cancer.
Publikationspreis 2026 (only available in German)
Die Preise sind mit jeweils 10.000 € für die private Verwendung der Preisträger dotiert. Bewerben können sich geförderte Wissenschaftlerinnen und Wissenschaftler der Förderlinien Erst- und Zweitantragstellung, der Else Kröner Memorialstipendien, der Else Kröner Forschungskollegs und Else Kröner Medical Scientist Kollegs.